Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Krebs

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|February 17, 2015
Weight-based hypoglycaemia treatment protocol for adults with Type 1 diabetes: a randomized crossover clinical trialL McTavish, J D Krebs, M Weatherall, et al.
Metabolism: Clinical and Experimental|July 16, 2004
Discrimination ratio analysis of inflammatory markers: implications for the study of inflammation in chronic diseaseL M Browning, J D Krebs, S A Jebb
Diabetic Medicine : a Journal of the British Diabetic Association|December 30, 2017
Weight-based carbohydrate treatment of hypoglycaemia in people with Type 1 diabetes using insulin pump therapy: a randomized crossover clinical trialL McTavish, B Corley, M Weatherall, et al.
The New Zealand Medical Journal|October 29, 2000
Follow up testing of hyperglycaemia during hospital admission: combined use of fasting plasma glucose and HbA1cJ D Krebs, G M Robinson, R B Smith, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 23, 2020
Intermittent fasting 5:2 diet: What is the macronutrient and micronutrient intake and composition?E L Scholtens, J D Krebs, B T Corley, et al.
Diabetes, Obesity & Metabolism|October 31, 2002
Changes in risk factors for cardiovascular disease with body fat loss in obese womenJ D Krebs, S Evans, L Cooney, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 7, 2018
Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trialB T Corley, R W Carroll, R M Hall, et al.
Diabetes, Obesity & Metabolism|January 4, 2007
The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotypeL M Browning, J D Krebs, C S Moore, et al.
International Journal of Obesity (2005)|March 23, 2006
Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic womenJ D Krebs, L M Browning, N K McLean, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|June 24, 2004
Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in womenL M Browning, S A Jebb, G D Mishra, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Diabetic Medicine : a Journal of the British Diabetic Association|February 17, 2015
Weight-based hypoglycaemia treatment protocol for adults with Type 1 diabetes: a randomized crossover clinical trialL McTavish, J D Krebs, M Weatherall, et al.
Metabolism: Clinical and Experimental|July 16, 2004
Discrimination ratio analysis of inflammatory markers: implications for the study of inflammation in chronic diseaseL M Browning, J D Krebs, S A Jebb
Diabetic Medicine : a Journal of the British Diabetic Association|December 30, 2017
Weight-based carbohydrate treatment of hypoglycaemia in people with Type 1 diabetes using insulin pump therapy: a randomized crossover clinical trialL McTavish, B Corley, M Weatherall, et al.
The New Zealand Medical Journal|October 29, 2000
Follow up testing of hyperglycaemia during hospital admission: combined use of fasting plasma glucose and HbA1cJ D Krebs, G M Robinson, R B Smith, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 23, 2020
Intermittent fasting 5:2 diet: What is the macronutrient and micronutrient intake and composition?E L Scholtens, J D Krebs, B T Corley, et al.
Diabetes, Obesity & Metabolism|October 31, 2002
Changes in risk factors for cardiovascular disease with body fat loss in obese womenJ D Krebs, S Evans, L Cooney, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 7, 2018
Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trialB T Corley, R W Carroll, R M Hall, et al.
Diabetes, Obesity & Metabolism|January 4, 2007
The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotypeL M Browning, J D Krebs, C S Moore, et al.
International Journal of Obesity (2005)|March 23, 2006
Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic womenJ D Krebs, L M Browning, N K McLean, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|June 24, 2004
Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in womenL M Browning, S A Jebb, G D Mishra, et al.
Pageof 2